In the field of gynecology, CAR T cells have the potential to revolutionize treatment for cancers such as ovarian, cervical, and endometrial cancer. These cancers are often diagnosed at advanced stages, making effective treatment options crucial. CAR T cells can be designed to target specific antigens expressed on the surface of cancer cells, offering a targeted and potentially more effective treatment option.